FGF23 and abnormal mineralization disorder: Expression of CYP27B2 is up and downregulated by parathormone (PTH) and fibroblast growth factor-23 (FGF-23) respectively in the context of chronic kidney disease and mineral bone disorder (CKD-MBD) (17).